Click a link below to view the mailing archive as if it had been sent to you.
| 2025-11-28 12:15 | | The next act for mRNA: pushing boundaries in cell and gene therapy and more... |
| 2025-11-26 12:15 | | Novo shares rise as US Medicare price cuts come in largely as expected and more... |
| 2025-11-26 00:15 | | AI Is Rewriting How Pharma Engages Patients And Doctors and more... |
| 2025-11-25 12:15 | | Novo Nordisk moves next-gen drug amycretin to late-stage diabetes trial after promising data and more... |
| 2025-11-25 00:15 | | Biogen’s Leqembi Rises After Novo GLP-1 Fails in Alzheimer’s and more... |
| 2025-11-24 12:15 | | Novo Nordisk Alzheimer's drug trials fail in blow to weight-loss giant and more... |
| 2025-11-24 00:15 | | Bayer reports positive results for blood thinner after 2023 setback and more... |
| 2025-11-21 12:15 | | Novo, Lilly said to sell obesity drugs directly to employers, bypassing PBMs and more... |
| 2025-11-21 00:15 | | Eli Lilly Enters Uncharted Territory as Market Cap Nears $1T and more... |
| 2025-11-20 12:15 | | Abbott to acquire Exact Sciences for about $21B and more... |
| 2025-11-20 00:15 | | Exact Sciences catapults on rumored Abbott Laboratories buyout and more... |
| 2025-11-19 12:15 | | After Lundbeck's surprise bid, Alkermes sweetens deal to acquire Avadel and more... |
| 2025-11-19 00:15 | | RNAi biotech Arrowhead wins first FDA approval and more... |
| 2025-11-18 12:15 | | Merck advances Winrevair in subset of heart failure patients and more... |
| 2025-11-18 00:15 | | Bayer opens Beijing incubator and names initial occupants, tightening ties to China and more... |
| 2025-11-17 12:15 | | J&J, aiming for $50b in cancer sales, buys Halda for $3b in cash and more... |
| 2025-11-17 00:15 | | Activist Starboard sells Pfizer stake after pushing for changes and more... |
| 2025-11-14 12:15 | | Merck pays $9.2B for Cidara, picking up flu antiviral spurned by J&J and more... |
| 2025-11-14 00:15 | | Kyowa Kirin, Kura snag FDA nod for oral AML drug Komzifti and more... |
| 2025-11-13 12:15 | | Gilead hails phase 3 victory for single-tablet combo of bictegravir and lenacapavir, preps filings and more... |
| 2025-11-13 00:15 | | FDA unveils new regulatory roadmap for bespoke drug therapies and more... |
| 2025-11-12 12:15 | | Bayer bails on Vividion tumor drug as part of early-stage cancer clear-out and more... |
| 2025-11-12 00:15 | | FDA names longtime oncology chief Richard Pazdur as its new CDER director and more... |
| 2025-11-11 12:15 | | Novo Nordisk shares mixed data behind pivotal heart disease push and more... |
| 2025-11-11 00:15 | | Novo forges partnership with Emcure to expand Wegovy access in India and more... |
| 2025-11-10 12:15 | | Eli Lilly pens $1.2B pact with Sanegene to better target metabolic RNA meds and more... |
| 2025-11-10 00:15 | | Pfizer wins bidding war for Metsera with $10B offer and more... |
| 2025-11-08 00:15 | | Price cuts help more Americans start weight-loss drugs but maybe not stay on them and more... |
| 2025-11-07 12:15 | | Novo CEO tells Pfizer to 'bid higher' if it wants to win Metsera and more... |
| 2025-11-07 00:15 | | Eli Lilly expects US FDA approval for oral obesity drug in March 2026 and more... |
| 2025-11-06 12:15 | | With 2030 ambitions in view, AstraZeneca’s quarterly revenue passes $15B for first time and more... |
| 2025-11-06 00:15 | | FTC warns Novo that current Metsera offer structure may violate US merger law and more... |
| 2025-11-05 12:15 | | After shaky Q3, Novo's new CEO says company's diabetes and obesity turnaround is a 'marathon, not a sprint' and more... |
| 2025-11-05 00:15 | | Billionaire-backed Arena BioWorks shutters less than 2 years after launch, cites ‘biotech macro conditions’ and more... |
| 2025-11-04 12:15 | | Pfizer tops estimates, raises profit guidance even as sales fall and more... |
| 2025-11-04 00:15 | | Sarepta's shares plunge after trial for muscle-wasting disease drugs miss key goal and more... |
| 2025-11-03 12:15 | | Kimberly-Clark agrees to buy Tylenol owner Kenvue in $48.7 billion deal, creating consumer staples giant and more... |
| 2025-11-03 00:15 | | Pfizer sues Metsera, Novo in effort to enforce buyout deal and more... |
